淡江大學機構典藏:Item 987654321/122692
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 60879/93651 (65%)
Visitors : 1188095      Online Users : 23
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library & TKU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://tkuir.lib.tku.edu.tw/dspace/handle/987654321/122692


    Title: Quality of life changes in patients undergoing treatment for hepatocellular carcinoma
    Authors: Chie, Wei-Chu;Yu, Fang;Li, Mengqian;Baccaglini, Lorena;Blazeby, Jane M;Hsiao, Chin-Fu;Chiu, Herng-Chia;Poon, Ronnie T;Mikoshiba, Naoko;Gillian, Al-Kadhimi;Heaton, Nigel;Calara, Jozer;Collins, Peter;Caddick, Katharine;Costantini, Anna;Vilgrain, Valerie;Chiang, Chieh
    Keywords: Quality of life;Asian;Treatment;Hepatocellular;Carcinoma
    Date: 2015-05-06
    Issue Date: 2022-05-09 12:10:22 (UTC+8)
    Abstract: Purpose
    Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. One of the primary treatment goals for incurable advanced cases is to prolong quality of life (QoL). Thus, to determine which HCC therapies may be linked to a more favorable QoL, we assessed the association between QoL changes and different treatments in HCC patients.

    Methods
    We analyzed a non-randomized multicenter longitudinal study, which included 171 patients treated with surgery (n = 53), ablation (n = 53) or embolization (n = 65) from seven centers: four Asian and three European sites. All participants completed the EORTC QLQ-C30 and QLQ-HCC18 questionnaires before and after treatment. Propensity scores were calculated and used in addition to race for adjustment in the logistic regression model to account for the confounding effects of patient characteristics including age, gender, race, employment, living with family, at least one comorbid condition, years since diagnosis, prior treatment history, BCLC stage, Child–Pugh grade, cirrhosis, bilirubin levels and QoL score before treatment.

    Results
    After adjustment for confounders, patients tended to have higher odds of QoL deterioration when treated with ablation versus embolization (dyspnea: p = 0.019; appetite loss: p = 0.018; body image: p = 0.035) or ablation versus surgery (dyspnea: p = 0.099; appetite loss: p = 0.100; body image: p = 0.038).

    Conclusions
    There were significant differences in QoL deterioration across different treatment groups. This information may assist patients and providers when selecting patient-centered treatment approaches for HCC.
    Relation: Quality of Life Research 24(10), 2499-2506
    DOI: 10.1007/s11136-015-0985-8
    Appears in Collections:[Graduate Institute & Department of Mathematics] Journal Article

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML6View/Open

    All items in 機構典藏 are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library & TKU Library IR teams. Copyright ©   - Feedback